Patients With Rheumatoid Arthritis (RA) Treated With Rituximab in Kuopio University Hospital

Completed

• Conditions: Rheumatoid Arthritis
• Interventions: Drug: rituximab; Drug: rituximab, observational study amon patients with active RA

• Registration Number: NCT00854321
• Lead Sponsor: Kuopio University Hospital

Brief Summary

One centre follow-up study on safety and efficacy of treatment with rituximab among patients with RA during 4 year period. Basic data is collected for the national register of biologicals.

Detailed Description

Data is collected on regular visits in the outpatient department. In collection national register forms have been used.

Basic Information
|
Recruitment & Eligibility
|
Study & Design
|
Trial Locations

Study Timeline

• Study Start: 2004-11
• Primary Completion: 2008-07
• Study Completion: 2008-07
• Status Verified: 2009-03
• Study First Submitted: 2009-03-02
• Study First Submitted QC: 2009-03-02
• Last Update Submitted: 2009-03-02
• Study First Posted: 2009-03-03
• Last Update Posted: 2009-03-03

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 49

Inclusion Criteria

• active RA without response to earlier treatment

Read More

Exclusion Criteria

• contraindications to rituximab

Read More

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
patients with active RA	rituximab	drug, follow-up
patients with active RA	rituximab, observational study amon patients with active RA	drug, follow-up

Primary Outcome Measures

Name	Time	Method
ACR20 ACR50 ACR70 response	6 and 12 months

Secondary Outcome Measures

Name	Time	Method
Duration of clinical response	6 and 12 months

Trial Locations

Locations (1)

Kuopio University Hospital; 🇫🇮 Kuopio, Finland